Prior studies have indicated that BCG increased IL6 production in human and murine bladder cancer cell lines by inducing G1 cell-cycle arrest while attenuating cell proliferation [7, 8], and IL6 inhibited tumor growth in murine bladder transitional carcinoma in vivo [2]. The gene discussed is IL6; the disease is neoplasm.